These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18095383)

  • 1. Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
    Thevis M; Kohler M; Schlörer N; Kamber M; Kühn A; Linscheid MW; Schänzer W
    J Mass Spectrom; 2008 May; 43(5):639-50. PubMed ID: 18095383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Thevis M; Kohler M; Thomas A; Schlörer N; Schänzer W
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2471-8. PubMed ID: 18634123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for metabolically stable aryl-propionamide-derived selective androgen receptor modulators for doping control purposes.
    Thevis M; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2006; 20(5):870-6. PubMed ID: 16470709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry of selective androgen receptor modulators.
    Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):865-76. PubMed ID: 18521833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding sports drug testing assays: mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.
    Thevis M; Piper T; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1173-82. PubMed ID: 23650030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
    Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
    J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S-4) for routine doping control purposes.
    Thevis M; Thomas A; Fusshöller G; Beuck S; Geyer H; Schänzer W
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2245-54. PubMed ID: 20623476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation.
    Thevis M; Volmer DA
    Eur J Mass Spectrom (Chichester); 2018 Feb; 24(1):145-156. PubMed ID: 29232975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification.
    Nielen MW; Bovee TF; van Engelen MC; Rutgers P; Hamers AR; van Rhijn JH; Hoogenboom LR
    Anal Chem; 2006 Jan; 78(2):424-31. PubMed ID: 16408923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for two selective androgen receptor modulators using gas chromatography-mass spectrometry in doping control analysis.
    Thevis M; Kohler M; Schlörer N; Fusshöller G; Schänzer W
    Eur J Mass Spectrom (Chichester); 2008; 14(3):153-61. PubMed ID: 18708695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry.
    Pozo OJ; Deventer K; Eenoo PV; Delbeke FT
    Anal Chem; 2008 Mar; 80(5):1709-20. PubMed ID: 18220370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
    Thevis M; Thomas A; Kohler M; Beuck S; Schänzer W
    J Mass Spectrom; 2009 Apr; 44(4):442-60. PubMed ID: 19373874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry of stanozolol and its analogues using electrospray ionization and collision-induced dissociation with quadrupole-linear ion trap and linear ion trap-orbitrap hybrid mass analyzers.
    Thevis M; Makarov AA; Horning S; Schänzer W
    Rapid Commun Mass Spectrom; 2005; 19(22):3369-78. PubMed ID: 16259046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
    Thevis M; Geyer H; Kamber M; Schänzer W
    Drug Test Anal; 2009 Aug; 1(8):387-92. PubMed ID: 20355219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron ionization mass spectrometry of the ryanodine receptor-based Ca(2+)-channel stabilizer S-107 and its implementation into routine doping control.
    Thevis M; Beuck S; Thomas A; Fusshöller G; Sigmund G; Schlörer N; Rodchenkov G; Schäfer M; Schänzer W
    Rapid Commun Mass Spectrom; 2009 Aug; 23(15):2363-70. PubMed ID: 19575395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.